Evotec trims 2026 outlook; Q2/H1 results set Aug 13 as key catalyst
Jul 13, 2026, 3:48 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The company slashed full-year guidance dramatically from €700-€780m revenue and €0-€40m EBITDA to €570-€610m and -€70 to -€105m, signaling higher cash burn and earnings stress. Historically, such downgrades trigger immediate stock weakness, especially when paired with a weak H1 EBITDA print and a still-elevated burn rate; the Aug 13 results become the near-term price catalyst.
AI summary
What happened, with direct paths to the underlying reporting
Evotec issued preliminary Q2 and H1 results with €300.1m revenue and -€42.7m adjusted EBITDA, alongside a widened liquidity cushion of about €465.6m. The full-year revenue outlook was cut to €570–€610m and EBITDA to -€70 to -€105m, a sharp downgrade from prior guidance of €700–€780m and €0–€40m, signaling higher cash burn and balance-sheet risk ahead of Aug 13 results.
Full-year 2026 guidance lowered to €570–€610m revenue; EBITDA -€70 to -€105m.
Prior guidance was €700–€780m revenue; €0–€40m EBITDA.
Results release scheduled for Aug 13, 2026.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
